Native Ligand-Inspired peptides for c-MET targeted PET probes development
European Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.1007/s00259-025-07403-y ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Renli Luo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine, College of Life and Health Sciences, Northeastern University, Shenyang, 110167, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-met, Positron-Emission Tomography, Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, State Key Laboratory of Drug Research.
Abstract (Originalsprache)
PURPOSE: Native ligand-derived peptides have significantly advanced the development of targeting ligands in radiopharmaceutical discovery and design. Herein, we report the first attempt to develop novel mesenchymal-epithelial transition factor (c-MET) targeted peptide positron emission tomography (PET) probes based on the endogenous biomolecule, hepatocyte growth factor (HGF). METHODS: Three c-MET targeted peptides were designed from the N-terminal and kringle 1 domain (NK1: 32-207 amino acid residues) of HGF. Then they were conjugated with chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and radiolabeled with [68Ga]GaCl3. The resulted [68Ga]Ga-labelled probes, [68Ga]Ga-DOTA-K1, [68Ga]Ga-DOTA-A-C5, and [68Ga]Ga-DOTA-A-M8 were evaluated in vitro and in vivo. RESULTS: Among three PET probes, [68Ga]Ga-DOTA-A-M8 exhibited a high affinity for c-MET (IC50 = 5.43 nM) and demonstrated specific and high uptake in c-MET highly expressing HCT-116 cells. Small animal PET/CT imaging clearly visualized the tumor with good contrast using [68Ga]Ga-DOTA-A-M8 over 120 min. Quantitative analysis of PET images revealed tumor uptake of [68Ga]Ga-DOTA-A-M8 at 30 min post-injection was 2.91 ± 0.20%ID/g in HCT-116 models. The probe was mainly cleared out through the kidney-bladder pathway. Biodistribution study showed HCT-116 tumor uptake of 2.84 ± 0.07%ID/g and 0.54 ± 0.09%ID/g in the normal and blocking mice group, respectively, at 30 min post-injection. The tumor-to-muscle, tumor-to-blood and tumor-to-liver ratios were 3.60 ± 1.09, 1.48 ± 0.24 and 2.48 ± 0.28, respectively, at 30 min. CONCLUSION: A novel c-MET-targeting PET probe, [68Ga]Ga-DOTA-A-M8, has been successfully developed in this study. It demonstrates high tumor-targeting capability and specificity. This study highlights developing PET probes based on native ligands is a powerful and generalizable strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Medicine, College of Life and Health Sciences, Northeastern University, Shenyang, 110167, China.
- State Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
- School of Biomedical Engineering, ShanghaiTech University, Shanghai, 201210, China.
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200235, China.
- School of Pharmacy, University of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing, 100049, China.
ORCID-Profile: Zhen Cheng
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- State Key Laboratory of Drug Research
- Gansu Science and Technology Major Project
- Ningbo Major Research and Development Plan Project
- Natural Science Foundation of Shanghai
- Shandong Laboratory Program
Zitieren
APA
Luo, R., Tan, B., Zhang, Y., Hu, J., Lin, J., Sun, L., Wei, X., Ju, N., Luo, X., Chen, C., Bao, J., Tao, J., Qu, Y., Qu, C., Li, R., Jiang, Y., Luo, Q., Cao, R., & Cheng, Z. (2025). Native Ligand-Inspired peptides for c-MET targeted PET probes development. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07403-y
Vancouver
Luo R, Tan B, Zhang Y, Hu J, Lin J, Sun L, et al. Native Ligand-Inspired peptides for c-MET targeted PET probes development. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07403-y
BibTeX
@article{Luo2025,
author = {Luo, Renli and Tan, Boyu and Zhang, Ying and Hu, Jing and Lin, Jia and Sun, Luming and Wei, Xiaonan and Ju, Nianting and Luo, Xiangning and Chen, Chuan and Bao, Junyu and Tao, Ji and Qu, Yanting and Qu, Chunrong and Li, Renda and Jiang, Yuanpeng and Luo, Quanyong and Cao, Rui and Cheng, Zhen},
title = {Native Ligand-Inspired peptides for c-MET targeted PET probes development},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.1007/s00259-025-07403-y}
}
EUVIMED